Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting (Companion Faculty Lecture)
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting (Companion Faculty Lecture)
-
Narrated by:
-
By:
About this listen
Featuring a slide presentation and related discussion from Dr Lindsey Roeker, including the following topics:
- Recent clinical updates with standard regimens for chronic lymphocytic leukemia (CLL) (0:00)
- Utility of minimal residual disease-guided treatment intensification after ibrutinib with venetoclax (7:03)
- Major long-term findings from the GLOW study of ibrutinib with venetoclax (10:35)
- Principal findings from the AMPLIFY study of acalabrutinib with venetoclax with or without obinutuzumab (12:28)
- Findings with combined acalabrutinib, venetoclax and obinutuzumab for patients with previously untreated high-risk disease (15:52)
- Early clinical findings with sonrotoclax and zanubrutinib as front-line treatment for CLL (18:12)
- Principal findings from the BRUIN CLL-321 trial of pirtobrutinib for patients who previously received a covalent Bruton tyrosine kinase (BTK) inhibitor (19:38)
- Emerging evidence with pirtobrutinib, venetoclax and obinutuzumab as front-line treatment (22:15)
- Novel strategy combining lisocabtagene maraleucel with ibrutinib for relapsed/refractory (R/R) CLL (24:13)
- Available data with epcoritamab monotherapy for R/R CLL (26:58)
- The emerging pharmacologic class of BTK degraders (29:04)
CME information and select publications
What listeners say about Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting (Companion Faculty Lecture)
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.